The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.

Day on March 24 was started to create awareness among people about a chronic, sinister but totally curable disease. Before, T.B. was considered a death warrant. But the discovery of the first anti-TB.

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Kenyans no longer have to wait several hours or days to know if they may have tuberculosis (TB), thanks to a new ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

MONDAY, April 21, 2025 (HealthDay News) — Immunotherapy might help keep lung cancer at bay for months or even years after the ...

AN AI-powered lung ultrasound tool has outperformed human experts in diagnosing pulmonary tuberculosis (TB), offering a fast, accessible, and sputum-free solution that could transform TB triage in ...